scorecardresearch
Add as a preferred source on Google
Saturday, September 12, 2026
Celebrating 9 Years
Support Our Journalism

Support our Journalism

9th Anniversary: Free Tote & Mug

Subscribe
TopicAnti-cancer drugs

Topic: anti-cancer drugs

IASST, IIT-Guwahati researchers develop ‘smart’ drug against aggressive breast cancer

A study published in the Journal of Medicinal Chemistry noted that many cancer cells produce an enzyme that helps them survive by neutralising anticancer drugs.

The liver flushes out cancer drugs before they reach tumors. Now, scientists have a solution

Researchers from the University of Texas, have found a way to change the gut microbiome and enhance the effectiveness of nanoparticle-based cancer drugs.

QR codes now mandatory on vaccines, anti-cancer drugs as govt hopes to curb fake pharma market

From top 300 pharma brands, Centre has expanded scope of QR code packaging to entire ranges of vaccines, anti-cancer medicines, antimicrobials, and narcotic and psychotropic drugs.

India gets first approved precision treatment for advanced prostate cancer. How Pluvicto works

Launched nationwide by Novartis, Pluvicto intravenously delivers radioactive doses to prostate cancer cells—a huge step in treating one of India’s top cancers

Scientists have found a better way to deliver cancer drugs—deeper in tumour, high precision

Unlike traditional antibody-drug conjugates, which struggle to move beyond the outer layers of tumours because of their size, affibodies are ten times smaller.

SC declines to restrain Zydus from selling cancer drug biosimilar, tells Bristol Myers to approach HC

A bench headed by the Chief Justice of India suggests Squibb to conduct a mapping exercise of Zydus product with their claimed patent to ascertain infringement, if any.

Budget cuts import costs of certain cancer & rare disease drugs. Why it offers little relief to patients

Cancer imposes catastrophic health expenditure in India, with medicines constituting over 60% of out-of-pocket expenditure. Research shows wide price variations, limited cost containment.

Drug costs form chunk of out-of-pocket spending on health in India. This could change with GST reforms

The Union Finance Ministry announced a five percent GST on all drugs and medicines from 22 September—down from the earlier 12 percent GST.

PGIMER report bats for new-age targeted lung cancer therapies to be included in AB-PMJAY

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly diagnosed advanced or metastatic non-small cell lung cancer.

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

On Camera

Srinagar’s cinemas may have gone dark. Kashmir’s love for films never did

It seemed like J&K's battered past had taken a backseat, even if it was for the four days of the international film festival.

Global funds sour on India stocks as some cut allocation to zero

Weak corporate earnings and the lack of an AI investment theme are prompting global investors to cut India exposure.

‘Society as battlefield’: NATO cites Indian military paper on cognitive warfare. What it says

In a seminal work, former military officers Lt. Gen. D.S. Hooda & Lt. Col. Pavithran Rajan put forth a framework to approach cognitive warfare, called Socio-Technical-Cognitive Battlespace.

The real BRICS story is what China, Russia want & India wishes

India, China and Russia share more contradictions than congruence. Each has a different worldview, as also a different adversary. The rude fact is that BRICS is the most irrelevant of all such groupings.